SCHEMBL4845846

SCHEMBL4845846

O=[N+]([O-])c1[c]scc1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TDP1 Q9NUW8 1/20 0.48
HPRT1 P00492 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 3/20 0.37
RAB9A P51151 2/20 0.37
CRHBP P24387 2/20 0.37
CRHR2 Q13324 2/20 0.37
PTGS2 P35354 3/20 0.36
MAPK1 P28482 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.34
CYP2A6 P11509 1/20 0.33
CYP2B6 P20813 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
MYC P01106 1/20 0.33
MAX P61244 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7045535 0.73 ALDH1A1 (0.47) ALDH1A1TDP1LMNARAB9ACRHBP
SCHEMBL3535919 0.70 ALDH1A1 (0.53) ALDH1A1TDP1HPRT1LMNAPOLB
SCHEMBL3459005 0.70 TDP1 (0.38) ALDH1A1TDP1POLBMAPK1KMT2A
SCHEMBL6047843 0.69 ALDH1A1 (0.47) ALDH1A1TDP1HPRT1LMNAPOLB
SCHEMBL6950450 0.68 CYP2A6 (0.43) ALDH1A1PTGS2MAPK1CYP2A6CYP2B6
SCHEMBL10406683 0.68 CYP2A6 (0.47) ALDH1A1PTGS2MAPK1CYP2A6CYP2B6
SCHEMBL7834701 0.68 ALDH1A1 (0.46) ALDH1A1TDP1HPRT1LMNAPOLB
SCHEMBL27556871 0.68 HPRT1 (0.47) ALDH1A1TDP1HPRT1LMNAPOLB
SCHEMBL9216438 0.68 MAPT (0.41) ALDH1A1TDP1LMNARAB9ACRHBP
SCHEMBL29236231 0.67 ALDH1A1 (0.59) ALDH1A1TDP1HPRT1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323458-B1 Dihydrobenzodiazepins and their use for treating dyslipidemia MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-01-29 US disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed